Respiratory Distress in Newborn Causes Symptoms Diagnosis Treatment Neonatology Guide
Paediatrics

Respiratory Distress in Newborn Causes Symptoms Diagnosis Treatment Neonatology Guide

Respiratory Distress in Newborn (Neonatal Respiratory Distress)

Definition

Respiratory distress in a newborn refers to difficulty in breathing occurring within the neonatal period (first 28 days of life). It is characterized by tachypnea and increased work of breathing due to inadequate oxygenation or ventilation.

Clinically, respiratory distress is suspected when a newborn shows two or more characteristic signs of increased respiratory effort.


1. Pathophysiology

Respiratory distress results from impaired gas exchange in the lungs, leading to hypoxemia, hypercapnia, and metabolic acidosis.

Mechanisms include:

  1. Surfactant deficiency

* Leads to alveolar collapse (atelectasis)

* Reduced lung compliance

* Seen in preterm infants.

  1. Delayed lung fluid clearance

* Retained fetal lung fluid → decreased air entry.

  1. Inflammation or infection

* Leads to alveolar damage and impaired oxygen diffusion.

  1. Airway obstruction

* Meconium, mucus, congenital airway anomalies.

  1. Persistent pulmonary hypertension

* Right-to-left shunting through ductus arteriosus or foramen ovale.


2. Causes of Respiratory Distress in Newborn

Pulmonary Causes

  • Respiratory Distress Syndrome (RDS)
  • Transient Tachypnea of Newborn (TTN)
  • Meconium Aspiration Syndrome
  • Pneumonia
  • Pneumothorax
  • Pulmonary hemorrhage
  • Congenital diaphragmatic hernia
  • Pulmonary hypoplasia

Cardiac Causes

  • Congenital heart disease
  • Persistent pulmonary hypertension of newborn (PPHN)

Infectious Causes

  • Neonatal sepsis
  • Congenital infections

Metabolic Causes

  • Hypoglycemia
  • Metabolic acidosis

Hematologic Causes

  • Severe anemia
  • Polycythemia

Neurologic Causes

  • Birth asphyxia
  • Intracranial hemorrhage

3. Risk Factors

  • Prematurity
  • Maternal diabetes
  • Cesarean delivery without labor
  • Perinatal asphyxia
  • Meconium-stained amniotic fluid
  • Prolonged rupture of membranes
  • Maternal infection

4. Clinical Features

Major Signs

  1. Tachypnea

* Respiratory rate >60 breaths/min

  1. Grunting

* Expiratory sound produced to maintain airway pressure.

  1. Nasal flaring

* Attempt to increase oxygen intake.

  1. Chest retractions

* Subcostal

* Intercostal

* Suprasternal

  1. Cyanosis

* Central cyanosis indicates severe hypoxia.


Additional Signs

  • Apnea
  • Poor feeding
  • Lethargy
  • Hypotonia

5. Assessment of Severity

Silverman–Anderson Score

Parameters assessed:

  • Chest movement
  • Intercostal retractions
  • Xiphoid retractions
  • Nasal flaring
  • Expiratory grunt

Score interpretation:

| Score | Severity |

| ----- | ----------------- |

| 0–3 | Mild distress |

| 4–6 | Moderate distress |

| 7–10 | Severe distress |


6. Investigations

1. Pulse Oximetry

  • Measures oxygen saturation.

2. Arterial Blood Gas (ABG)

Findings:

  • Hypoxemia
  • Hypercapnia
  • Metabolic acidosis

3. Chest X-Ray

Helps identify cause:

Examples:

  • Ground glass appearance → RDS
  • Hyperinflation → TTN
  • Patchy infiltrates → pneumonia or meconium aspiration
  • Air leak → pneumothorax

4. Laboratory Tests

  • CBC
  • CRP
  • Blood culture
  • Blood glucose
  • Electrolytes

5. Echocardiography

  • If congenital heart disease suspected.

7. Differential Diagnosis

Conditions presenting similarly:

  • Respiratory Distress Syndrome
  • Transient Tachypnea of Newborn
  • Meconium Aspiration Syndrome
  • Neonatal pneumonia
  • Congenital heart disease
  • Pneumothorax
  • Persistent pulmonary hypertension

8. Management

Management depends on severity and underlying cause.


Stepwise Management

Step 1: Initial Stabilization

  • Maintain airway
  • Provide warmth
  • Position baby (sniffing position)
  • Clear secretions if needed
  • Monitor vital signs

Step 2: Oxygen Therapy

Indications:

  • SpO₂ < 90–92%

Methods:

  • Oxygen hood
  • Nasal cannula
  • Continuous Positive Airway Pressure (CPAP)

Target oxygen saturation:

  • 90–95%

Step 3: CPAP (Continuous Positive Airway Pressure)

Indications:

  • Moderate respiratory distress
  • RDS
  • Oxygen requirement >40%

Benefits:

  • Prevents alveolar collapse
  • Improves oxygenation.

Step 4: Mechanical Ventilation

Indications:

  • Severe respiratory distress
  • Apnea
  • Respiratory failure
  • Persistent hypoxemia despite CPAP

Step 5: Treat Underlying Cause

Examples:

| Cause | Treatment |

| ------------ | ------------------ |

| RDS | Surfactant therapy |

| TTN | Supportive care |

| Pneumonia | Antibiotics |

| Pneumothorax | Needle aspiration |

| PPHN | Nitric oxide |


9. Drug Therapy

Surfactant Therapy

Indication

  • Neonatal Respiratory Distress Syndrome (especially in preterm infants).

Mechanism of Action

Surfactant reduces alveolar surface tension, preventing alveolar collapse during expiration and improving lung compliance.

Common Preparations

  • Beractant
  • Poractant alfa

Usual Dosing

  • Beractant: 100 mg/kg intratracheally
  • Poractant alfa: 100–200 mg/kg intratracheally

Pharmacokinetics

  • Acts locally in lungs
  • Rapid improvement in oxygenation.

Adverse Effects

Common:

  • Transient bradycardia
  • Oxygen desaturation

Serious:

  • Pulmonary hemorrhage
  • Air leak syndrome

Contraindications

  • Severe congenital anomalies incompatible with life.

Monitoring

  • Oxygen saturation
  • Blood gases
  • Ventilator settings.

Counseling Points

  • Early treatment improves survival.
  • Used mainly in preterm babies.

Antibiotics (if infection suspected)

Common Regimen

Ampicillin

Indication

  • Neonatal sepsis and pneumonia.

Mechanism

  • Inhibits bacterial cell wall synthesis.

Dose

  • 50 mg/kg IV every 12 hours (neonates).

Adverse Effects

  • Rash
  • Diarrhea
  • Allergic reactions

Gentamicin

Mechanism

  • Inhibits bacterial protein synthesis.

Dose

  • 4–5 mg/kg IV once daily.

Adverse Effects

  • Nephrotoxicity
  • Ototoxicity

Monitoring

  • Renal function
  • Drug levels if prolonged therapy.

10. Non-Pharmacological Measures

  • Maintain neutral thermal environment
  • Adequate nutrition
  • IV fluids
  • Minimal handling
  • Infection control
  • Monitor glucose and electrolytes.

11. Complications

If untreated or severe:

  • Respiratory failure
  • Pneumothorax
  • Bronchopulmonary dysplasia
  • Hypoxic brain injury
  • Death

12. Prevention

  • Antenatal corticosteroids in preterm labor
  • Good antenatal care
  • Prevention of prematurity
  • Skilled neonatal resuscitation
  • Early breastfeeding
  • Infection prevention

If you want, I can also give MCQ exam questions on neonatal respiratory distress (very high yield for NEET PG / NEXT / pediatrics exams).

Interactive MCQ Quiz

MCQ Exam Mode

15 Questions
Question 1 of 15

Frequently Asked Questions

Respiratory distress in newborn is a condition where a baby has difficulty breathing during the first 28 days of life. It is characterized by tachypnea, grunting, nasal flaring, chest retractions, and sometimes cyanosis due to impaired oxygen exchange in the lungs.
Major causes include respiratory distress syndrome, transient tachypnea of the newborn, meconium aspiration syndrome, neonatal pneumonia, persistent pulmonary hypertension of the newborn, pneumothorax, congenital diaphragmatic hernia, pulmonary hypoplasia, and congenital heart disease.
Common signs include tachypnea with respiratory rate above 60 breaths per minute, nasal flaring, expiratory grunting, chest retractions, cyanosis, poor feeding, and lethargy.
The Silverman Anderson score is used to assess the severity of respiratory distress in newborns. It evaluates chest movement, intercostal retractions, xiphoid retractions, nasal flaring, and expiratory grunting.
Diagnosis is based on clinical examination and investigations such as pulse oximetry, arterial blood gas analysis, chest X ray, blood tests including CBC and CRP, blood culture, and sometimes echocardiography.
Respiratory distress syndrome is a lung condition mainly seen in premature infants caused by surfactant deficiency leading to alveolar collapse and impaired gas exchange.
Transient tachypnea of the newborn is a mild respiratory condition caused by delayed clearance of fetal lung fluid. It commonly occurs in babies born by cesarean section and usually resolves within 48 to 72 hours.
Treatment depends on severity and cause and may include oxygen therapy, continuous positive airway pressure, mechanical ventilation, surfactant therapy for respiratory distress syndrome, antibiotics for infection, and supportive care.
Possible complications include respiratory failure, pneumothorax, bronchopulmonary dysplasia, hypoxic brain injury, persistent pulmonary hypertension, and death if severe and untreated.
Prevention includes good antenatal care, administration of antenatal corticosteroids in preterm labor, prevention of prematurity, proper neonatal resuscitation at birth, infection control, and early monitoring of high risk newborns.